NR4A1 and cancer: If, indeed, higher TSH levels denote subclinical hypothyroidism, these data suggest that hormone-receptor-positive/HER2-positive cancer patients are more commonly euthyroid than patients with hormone-receptor-positive/HER2-negative cancers.